← Back to Clinical Trials
Recruiting NCT03293758
NCT03293758 Food and Microbiome Longitudinal Investigation (FAMiLI)
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT03293758 |
| Status | Recruiting |
| Phase | — |
| Sponsor | NYU Langone Health |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 16,000 participants |
| Start Date | 2016-05-16 |
| Primary Completion | 2029-12-31 |
Trial Parameters
Condition Cancer
Sponsor NYU Langone Health
Study Type OBSERVATIONAL
Phase N/A
Enrollment 16,000
Sex ALL
Min Age 40 Years
Max Age N/A
Start Date 2016-05-16
Completion 2029-12-31
All Conditions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The NYU Human Microbiome Study Cohort is designed to improve understanding of the role of human microbiome in health and disease. This study will serve as a critical NYU biorepository resource for research on human genetics and the microbiome in health and disease
Eligibility Criteria
Inclusion Criteria: * Age \> 40 Exclusion Criteria: * Use of long term antibiotics. * Pregnant
Related Trials
NCT02070328
Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-up
View Trial →
NCT07262632
Developing a Multimodal Cancer Pain Database to Support AI-Based Automatic Pain Assessment
View Trial →
NCT07319039
Breathlessness Patterns in Patients With Cancer, COPD and Heart Failure: an fMRI Feasibility Study
View Trial →
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology